Jefferies Maintains a 'Buy' on Insulet Corp (PODD)Waiting for the Next Gen Pod

Jefferies maintains a 'Buy' on Insulet Corporation (NASDAQ: PODD) price target raised from $21 to $24.

Jefferies analyst says, "Insulet closed out 2011 with 4Q sales of $47.2mn, largely in-line with expectations. The company remains in active communication with the FDA on the next gen pod, with approval expected by the end of 1Q/early 2Q. The launch of the next gen pod is anticipated at ADA in June and will have a positive impact on both revenue growth and profitability."

Jefferies lowers FY12 EPS loss from (0.42) to (0.90) and FY13 from $0.34 to (0.05).

For an analyst ratings summary and ratings history on Insulet Corporation click here. For more ratings news on Insulet Corporation click here.

Shares of Insulet Corporation closed at $19.88 yesterday, with a 52 week range of $14.00-$23.33.

---

Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!

You May Also Be Interested In

• Barclays Maintains an 'Equalweight' on J. C. Penney (JCP); Slashing PT on Disappointing Results
• Barclays Raises Estimates on Williams-Sonoma (WSM); Encouraging Q1 Results
• UBS Maintains a 'Buy' on Express Inc. (EXPR); A Misstep, But Still A Consistent Performer

Create E-mail Alert Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Related Entities

Jefferies & Co

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter